RECALL: Franck's Compounding Triamcinolone Acetonide Recall

Share this article:

Franck's Compounding Pharmacy has recalled one additional lot of triamcinolone acetonide PF 80mg/mL. The Centers for Disease Control and Prevention (CDC) has advised healthcare personnel to avoid use of compounded products labeled as sterile from Franck's Compounding Pharmacy during this time of ongoing investigation.

On March 19, 2012, Franck's announced a recall for Brilliant Blue G following reports of fungal endophthalmitis in patients who were given Brilliant Blue G (BBG) during eye surgeries. On April 20, 2012, the FDA issued a second warning to physicians regarding certain compounded drugs from Franck's. In addition, Franck's had recalled one lot of triamcinolone acetonide PF following reports of eye infections in patients who were given injections during eye surgery.

These drugs were supplied by Franck's Pharmacy in Ocala, FL. Healthcare personnel are advised to stop use of all sterile triamcinolone-containing products purchased from Franck's until further notice.

For more information visit www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm296383.htm.

Share this article:

Related Resources

close

Next Article in Safety Alerts and Recalls